CN109925500A - 一种植物蛋白粉 - Google Patents
一种植物蛋白粉 Download PDFInfo
- Publication number
- CN109925500A CN109925500A CN201711369465.4A CN201711369465A CN109925500A CN 109925500 A CN109925500 A CN 109925500A CN 201711369465 A CN201711369465 A CN 201711369465A CN 109925500 A CN109925500 A CN 109925500A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- dietary fiber
- plant protein
- protein powder
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 31
- 108010064851 Plant Proteins Proteins 0.000 title claims abstract description 27
- 235000021118 plant-derived protein Nutrition 0.000 title claims abstract description 27
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 17
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 12
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 12
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 12
- 239000001527 calcium lactate Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 11
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 11
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 229960002477 riboflavin Drugs 0.000 claims abstract description 11
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 11
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 11
- 239000000835 fiber Substances 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241000721047 Danaus plexippus Species 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 229960005070 ascorbic acid Drugs 0.000 claims description 7
- 229920001100 Polydextrose Polymers 0.000 claims description 6
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 239000001259 polydextrose Substances 0.000 claims description 6
- 229940035035 polydextrose Drugs 0.000 claims description 6
- 235000013856 polydextrose Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- 101710089165 Protein white Proteins 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000010348 incorporation Methods 0.000 claims description 3
- 238000012946 outsourcing Methods 0.000 claims description 3
- 238000012797 qualification Methods 0.000 claims description 3
- 229920006300 shrink film Polymers 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 206010010774 Constipation Diseases 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 8
- 239000003053 toxin Substances 0.000 abstract description 7
- 231100000765 toxin Toxicity 0.000 abstract description 7
- 208000005016 Intestinal Neoplasms Diseases 0.000 abstract description 4
- 201000002313 intestinal cancer Diseases 0.000 abstract description 4
- 230000001473 noxious effect Effects 0.000 abstract description 4
- 230000029087 digestion Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 8
- 230000018678 bone mineralization Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种植物蛋白粉,其特征在于,所述植物蛋白粉由五种水溶性膳食纤维,一种非水溶性膳食纤维以及左旋肉碱、维生素B2、维生素C、乳酸钙等食物纤维按照君臣佐使的原则进行科学配比制成。本发明通过在植物蛋白粉中添加水溶性膳食纤维和非水溶性膳食纤维不仅可以预防便秘,促进肠道的消化;同时可降低患肠癌的风险,同时能够吸收食物中的有毒物质,预防便秘并弱化消化道中细菌排出的毒素。
Description
技术领域
本发明涉及化学医药技术领域,更具体的说是涉及一种植物蛋白粉。
背景技术
当前市面上的植物蛋白膳食纤维粉或片里的成份只是普通的膳食纤维,没有功能性的食物纤维,而且没有科学的配比,仅仅是简单的混合,故市面上的膳食纤维产品没有促进肠道益生菌生长的作用;没有促进肠道粘膜损伤修复的作用;没有促进重金属排出的作用;没有改善便秘的作用;没有减轻体重的作用;没有降低血糖的作用。
因此,如何提供一种具有预防便秘并弱化消化道中细菌排出的毒素、促进新陈代谢以及皮肤和细胞膜完整性、促进骨骼钙化形成特点的植物蛋白粉是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明提供了一种具有预防便秘并弱化消化道中细菌排出的毒素、促进新陈代谢以及皮肤和细胞膜完整性、促进骨骼钙化形成特点的植物蛋白粉。
为实现上述目的,本发明提供如下技术方案:
一种植物蛋白粉,其特征在于,所述植物蛋白粉由五种水溶性膳食纤维,一种非水溶性膳食纤维以及左旋肉碱、维生素B2、维生素C、乳酸钙等食物纤维按照君臣佐使的原则进行科学配比制成;其中,所述水溶性膳食纤维和非水溶性膳食纤维的添加比例为:大豆分离蛋白42%、聚葡萄糖24%、低聚异麦芽糖12%、低聚木糖0.5%、水苏糖0.5%;非水溶性膳食纤维非水溶性大豆膳食纤维7%;所述维生素及矿物质的添加比例为:左旋肉碱0.5%、维生素B20.002%、维生素c 0.1%、乳酸钙0.84%。
优选的,在上述一种植物蛋白粉中,具体的制备方法为:(1)将上述检验合格的原料:大豆分离蛋白粉、聚葡萄糖、大豆膳食纤维、低聚异麦芽糖、低聚木糖、水苏糖、左旋肉碱、维生素B2、维生素c、乳酸钙按工艺处方配比在配料车间过筛80目,过筛后所有物料在称量间用电子秤进行称量;(2)把称量车间称量好的物料通过传递窗传递到槽型混合车间,把物料投放到CH-200混合机里,按工艺要求设定混合时间15分钟,用不锈钢桶放出物料过20目筛;(3)将混合好的物料通过传递窗传递到分装车间进行分装(分装机DXD-40LL机型号),分装机设定速度为30袋/分装,每袋净含量20克,每10分钟检查一次净含量,要求净含量达到20.5-21克之间;(4)将分装好的植物蛋白粉传递窗到外包车间进行包装,每盒装30袋,外套收缩膜进行收缩,收缩完的康培尼植物蛋白粉装箱;(5)产品化验室检测合格入库。
经由上述的技术方案可知,与现有技术相比,本发明公开提供了一种植物蛋白粉,其特征在于,所述植物蛋白粉由五种水溶性膳食纤维,一种非水溶性膳食纤维以及左旋肉碱、维生素B2、维生素C、乳酸钙等食物纤维按照君臣佐使的原则进行科学配比制成。本发明通过在植物蛋白粉中添加水溶性膳食纤维和非水溶性膳食纤维不仅可以预防便秘,促进肠道的消化;同时可降低患肠癌的风险,同时能够吸收食物中的有毒物质,预防便秘并弱化消化道中细菌排出的毒素。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明实施例公开了一种具有预防便秘并弱化消化道中细菌排出的毒素、促进新陈代谢以及皮肤和细胞膜完整性、促进骨骼钙化形成特点的植物蛋白粉。
请参阅本发明公开的一种植物蛋白粉,具体包括:
植物蛋白粉由五种水溶性膳食纤维,一种非水溶性膳食纤维以及左旋肉碱、维生素B2、维生素C、乳酸钙等食物纤维按照君臣佐使的原则进行科学配比制成;其中,水溶性膳食纤维和非水溶性膳食纤维的添加比例为:大豆分离蛋白42%、聚葡萄糖24%、低聚异麦芽糖12%、低聚木糖0.5%、水苏糖0.5%;非水溶性膳食纤维非水溶性大豆膳食纤维7%;所述维生素及矿物质的添加比例为:左旋肉碱0.5%、维生素B2 0.002%、维生素c 0.1%、乳酸钙0.84%。
本发明通过在植物蛋白粉中添加水溶性膳食纤维和非水溶性膳食纤维不仅可以预防便秘,促进肠道的消化;同时可降低患肠癌的风险,同时能够吸收食物中的有毒物质,预防便秘并弱化消化道中细菌排出的毒素。
为了进一步优化上述技术方案,具体的制备方法为:(1)将上述检验合格的原料:大豆分离蛋白粉、聚葡萄糖、大豆膳食纤维、低聚异麦芽糖、低聚木糖、水苏糖、左旋肉碱、维生素B2、维生素c、乳酸钙按工艺处方配比在配料车间过筛80目,过筛后所有物料在称量间用电子秤进行称量;(2)把称量车间称量好的物料通过传递窗传递到槽型混合车间,把物料投放到CH-200混合机里,按工艺要求设定混合时间15分钟,用不锈钢桶放出物料过20目筛;(3)将混合好的物料通过传递窗传递到分装车间进行分装(分装机DXD-40LL机型号),分装机设定速度为30袋/分装,每袋净含量20克,每10分钟检查一次净含量,要求净含量达到20.5-21克之间;(4)将分装好的植物蛋白粉传递窗到外包车间进行包装,每盒装30袋,外套收缩膜进行收缩,收缩完的康培尼植物蛋白粉装箱;(5)产品化验室检测合格入库。
为了进一步优化上述技术方案,水溶性膳食纤维可以防治便秘,预防结肠和直肠癌,防治痔疮,降低血脂,预防冠心病,改善糖尿病症状,改善口腔及牙齿功能,防治胆结石,预防妇女乳腺癌:据流行病学发现,乳腺癌的发生与膳食中高脂肪、高糖、高肉类及低膳食纤维摄入有关。
为了进一步优化上述技术方案,非水溶性纤维可降低患肠癌的风险,同时能够吸收食物中的有毒物质,预防便秘并弱化消化道中细菌排出的毒素。
为了进一步优化上述技术方案,左旋肉碱的功能:左旋肉碱是脂肪代谢过程中一种必须的辅酶,能促进脂肪酸进入线粒体进行氧化分解。
为了进一步优化上述技术方案,维生素B2参与生物氧化与能量代谢,提高机体对蛋白质的利用率、促进皮肤和细胞膜完整性,是机体组织代谢必须的营养素。
为了进一步优化上述技术方案,维生素c的作用:是高效抗氧化剂、抗自由基、参与组织修补及铁的吸收、促进重金属排除、保护肝脏。
为了进一步优化上述技术方案,乳酸钙的作用:是钙补充剂,促进骨骼钙化形成,维持神经与肌肉正常兴奋性、降低毛细管通透性等作用。
本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。对于实施例公开的装置而言,由于其与实施例公开的方法相对应,所以描述的比较简单,相关之处参见方法部分说明即可。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (2)
1.一种植物蛋白粉,其特征在于,所述植物蛋白粉由五种水溶性膳食纤维,一种非水溶性膳食纤维以及左旋肉碱、维生素B2、维生素C、乳酸钙等食物纤维按照君臣佐使的原则进行科学配比制成;其中,所述水溶性膳食纤维和非水溶性膳食纤维的添加比例为:大豆分离蛋白42%、聚葡萄糖24%、低聚异麦芽糖12%、低聚木糖0.5%、水苏糖0.5%;非水溶性膳食纤维非水溶性大豆膳食纤维7%;所述维生素及矿物质的添加比例为:左旋肉碱0.5%、维生素B20.002%、维生素c 0.1%、乳酸钙0.84%。
2.根据权利要求1所述的植物蛋白粉,其特征在于,具体的制备方法为:(1)将上述检验合格的原料:大豆分离蛋白粉、聚葡萄糖、大豆膳食纤维、低聚异麦芽糖、低聚木糖、水苏糖、左旋肉碱、维生素B2、维生素c、乳酸钙按工艺处方配比在配料车间过筛80目,过筛后所有物料在称量间用电子秤进行称量;(2)把称量车间称量好的物料通过传递窗传递到槽型混合车间,把物料投放到CH-200混合机里,按工艺要求设定混合时间15分钟,用不锈钢桶放出物料过20目筛;(3)将混合好的物料通过传递窗传递到分装车间进行分装(分装机DXD-40LL机型号),分装机设定速度为30袋/分装,每袋净含量20克,每10分钟检查一次净含量,要求净含量达到20.5-21克之间;(4)将分装好的植物蛋白粉传递窗到外包车间进行包装,每盒装30袋,外套收缩膜进行收缩,收缩完的康培尼植物蛋白粉装箱;(5)产品化验室检测合格入库。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210878380.3A CN115252761A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
CN201711369465.4A CN109925500A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711369465.4A CN109925500A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210878380.3A Division CN115252761A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109925500A true CN109925500A (zh) | 2019-06-25 |
Family
ID=66983037
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711369465.4A Pending CN109925500A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
CN202210878380.3A Pending CN115252761A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210878380.3A Pending CN115252761A (zh) | 2017-12-19 | 2017-12-19 | 一种植物蛋白粉 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN109925500A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000060487A (ja) * | 1998-08-27 | 2000-02-29 | Kao Corp | 便秘改善剤 |
CN1559292A (zh) * | 2004-03-05 | 2005-01-05 | 南阳市海达生物技术有限公司 | 一种膳食纤维配方及其制备方法 |
CN101606704A (zh) * | 2009-05-27 | 2009-12-23 | 北京东方兴企食品工业技术有限公司 | 一种具有多种功能作用的膳食纤维食品 |
CN104287049A (zh) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | 一种体重管理的代餐蛋白质粉固体饮料 |
CN106954862A (zh) * | 2017-03-31 | 2017-07-18 | 北京市永康年健康科技有限责任公司 | 膳食纤维制品及其制备方法 |
-
2017
- 2017-12-19 CN CN201711369465.4A patent/CN109925500A/zh active Pending
- 2017-12-19 CN CN202210878380.3A patent/CN115252761A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000060487A (ja) * | 1998-08-27 | 2000-02-29 | Kao Corp | 便秘改善剤 |
CN1559292A (zh) * | 2004-03-05 | 2005-01-05 | 南阳市海达生物技术有限公司 | 一种膳食纤维配方及其制备方法 |
CN101606704A (zh) * | 2009-05-27 | 2009-12-23 | 北京东方兴企食品工业技术有限公司 | 一种具有多种功能作用的膳食纤维食品 |
CN104287049A (zh) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | 一种体重管理的代餐蛋白质粉固体饮料 |
CN106954862A (zh) * | 2017-03-31 | 2017-07-18 | 北京市永康年健康科技有限责任公司 | 膳食纤维制品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115252761A (zh) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102150836B (zh) | 氨糖多肽软胶囊 | |
CN108618129A (zh) | 肌肉衰减综合症专用型临床营养配方及其制备方法 | |
US20210128481A1 (en) | Plant soft capsule and preparation method and application thereof | |
CN101991112A (zh) | 一种能够稳定餐后血糖功能的保健食品 | |
CN103719282A (zh) | 一种中老年配方奶粉 | |
CN105613789A (zh) | 一种高脂高膳食纤维复合动植物粉末油脂、其制备方法及应用 | |
CN103431392B (zh) | 一种供糖尿病患者食用的复合海洋特膳食品 | |
JP5157007B2 (ja) | 骨強化剤 | |
JP2007049952A (ja) | 麺線生地及びその製造方法 | |
CN109276710A (zh) | 一种增加骨密度的组合物及其制备方法和用途 | |
CN101874632A (zh) | 一种胶原鹿骨钙胶囊及其制备方法 | |
Evgeniy et al. | Dietary fibres in preventative meat products | |
CN103404765B (zh) | 一种供肿瘤患者食用的复合海洋特膳食品 | |
CN107440102A (zh) | 一种更年期女性专用型临床营养配方及其制备方法 | |
WO2007140277A1 (en) | Method for embedding and targeted release of micronutrients in activated dietary fibers | |
CN107898955B (zh) | 一种促进猪生长发育的药物、其制备方法及应用 | |
CN109925500A (zh) | 一种植物蛋白粉 | |
CN102232561A (zh) | 枸杞纤维素胶囊及其制备方法 | |
CN107509996A (zh) | 一种骨膳食营养粉及其制备方法 | |
CN104770658A (zh) | 非油炸波纹面用富硒小麦粉、面粉及波纹面 | |
CN109925505A (zh) | 一种压片糖果 | |
CN107198179A (zh) | 一种保健营养早餐配方及其制作方法 | |
CN104379001B (zh) | 获自酿造过程产生的生物质的脂肪粘结剂 | |
CN109007693A (zh) | 一种大麦若叶青汁魔芋的加工方法 | |
CN100413425C (zh) | 具有降脂降糖功能的膳食纤维组合物及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190625 |
|
RJ01 | Rejection of invention patent application after publication |